669 related articles for article (PubMed ID: 18173080)
21. [Comparative study of indirect immunofluorescence (IIF) and ELISA techniques in the detection of parvovirus B19].
González M; Hassanhi M; Rivera S; Bracho MP
Invest Clin; 2000 Mar; 41(1):19-27. PubMed ID: 10758696
[TBL] [Abstract][Full Text] [Related]
22. Serological study of parvovirus B19 infection in women with recurrent spontaneous abortions.
Kishore J; Gupta I
Indian J Pathol Microbiol; 2006 Oct; 49(4):548-50. PubMed ID: 17183849
[TBL] [Abstract][Full Text] [Related]
23. Parvovirus B19 infection in Chile: markers of infection and immunity in patients with clinical symptoms.
Larrañaga C; León O; Díaz P; Miranda M; Norambuena X; Pérez M; Gaggero A
J Med Virol; 2007 Dec; 79(12):1927-34. PubMed ID: 17935173
[TBL] [Abstract][Full Text] [Related]
24. A high prevalence of parvovirus B19 DNA in patients with psoriasis.
Yazici AC; Aslan G; Baz K; Ikizoglu G; Api H; Serin MS; Tezcan S; Emekdas G; Tasdelen B
Arch Dermatol Res; 2006 Oct; 298(5):231-5. PubMed ID: 16862431
[TBL] [Abstract][Full Text] [Related]
25. Human parvovirus B19 in cord blood of premature infants.
Koga M; Matsuoka T; Katayama K; Takeda K; Nakata M; Sase M; Kato H; Furukawa S
Am J Perinatol; 2001 Aug; 18(5):237-40. PubMed ID: 11552176
[TBL] [Abstract][Full Text] [Related]
26. Relevance of B19 markers in serum samples for a diagnosis of parvovirus B19-correlated diseases.
Gallinella G; Zuffi E; Gentilomi G; Manaresi E; Venturoli S; Bonvicini F; Cricca M; Zerbini M; Musiani M
J Med Virol; 2003 Sep; 71(1):135-9. PubMed ID: 12858419
[TBL] [Abstract][Full Text] [Related]
27. Seroepidemiology of human parvovirus B19 in Taiwan.
Lin KH; You SL; Chen CJ; Wang CF; Yang CS; Yamazaki S
J Med Virol; 1999 Feb; 57(2):169-73. PubMed ID: 9892403
[TBL] [Abstract][Full Text] [Related]
28. Presence and significance of human parvovirus B19 DNA in synovial membranes and bone marrow from patients with arthritis of unknown origin.
Cassinotti P; Siegl G; Michel BA; Brühlmann P
J Med Virol; 1998 Nov; 56(3):199-204. PubMed ID: 9783685
[TBL] [Abstract][Full Text] [Related]
29. Investigation of parvovirus B19 seroprevalence, endothelin-1 synthesis, and nitric oxide levels in the etiology of essential hypertension.
Motor VK; Arica S; Motor S; Yilmaz N; Evirgen O; Inci M; Gokce C; Onlen Y
Clin Exp Hypertens; 2012; 34(3):217-21. PubMed ID: 22468640
[TBL] [Abstract][Full Text] [Related]
30. Human parvovirus B19 infection during pregnancy--value of modern molecular and serological diagnostics.
Enders M; Schalasta G; Baisch C; Weidner A; Pukkila L; Kaikkonen L; Lankinen H; Hedman L; Söderlund-Venermo M; Hedman K
J Clin Virol; 2006 Apr; 35(4):400-6. PubMed ID: 16332455
[TBL] [Abstract][Full Text] [Related]
31. Is routine viral screening useful in patients with recent-onset polyarthritis of a duration of at least 6 weeks? Results from a nationwide longitudinal prospective cohort study.
Varache S; Narbonne V; Jousse-Joulin S; Guennoc X; Dougados M; Daurès JP; Devauchelle-Pensec V; Saraux A
Arthritis Care Res (Hoboken); 2011 Nov; 63(11):1565-70. PubMed ID: 21954118
[TBL] [Abstract][Full Text] [Related]
32. Human parvovirus b19 infection in patients with coronary atherosclerosis.
Liu SC; Tsai CT; Wu CK; Yu MF; Wu MZ; Lin LI; Wang SS; Hwang JJ; Tseng YZ; Chiang FT; Tseng CD
Arch Med Res; 2009 Oct; 40(7):612-7. PubMed ID: 20082878
[TBL] [Abstract][Full Text] [Related]
33. [Diagnosis of parvovirus B19 infection in hematological patients with partial red cell aplasia of the bone marrow].
Iaguzhinskaia OE; Pivnik AV; Fevraleva IS; Sudarikov AB; Lisovina IuS; Loginova IV; Shitareva IV
Ter Arkh; 2001; 73(8):50-6. PubMed ID: 11599268
[TBL] [Abstract][Full Text] [Related]
34. Prevalence and quantitation of parvovirus B19 DNA levels in blood donors with a sensitive polymerase chain reaction screening assay.
Kleinman SH; Glynn SA; Lee TH; Tobler L; Montalvo L; Todd D; Kiss JE; Shyamala V; Busch MP;
Transfusion; 2007 Oct; 47(10):1756-64. PubMed ID: 17880600
[TBL] [Abstract][Full Text] [Related]
35. Chronic fatigue syndrome after human parvovirus B19 infection without persistent viremia.
Seishima M; Mizutani Y; Shibuya Y; Arakawa C
Dermatology; 2008; 216(4):341-6. PubMed ID: 18277075
[TBL] [Abstract][Full Text] [Related]
36. Parvovirus B19 infection in pediatric oncology patients: diagnostic value of clinical and serologic parameters compared with nested PCR.
Soliman Oel-S; Abd El-Aal Hegazi Hasan M; El-Ashry R; Zaghloul MH; Kora B
J Pediatr Hematol Oncol; 2009 Mar; 31(3):173-6. PubMed ID: 19262242
[TBL] [Abstract][Full Text] [Related]
37. [Diagnosis for human parvovirus B19-polyarthritis: usefulness of empty particle B19.ELISA and B19-DNA.PCR].
Hatakeyama Y; Ishii K; Murai C; Sugamura K; Mitomo N; Saitoh T; Rikimaru Y; Okazaki T; Sasaki T
Ryumachi; 1998 Oct; 38(5):689-95. PubMed ID: 9852745
[TBL] [Abstract][Full Text] [Related]
38. Prevalence of parvovirus B19 and human bocavirus DNA in the heart of patients with no evidence of dilated cardiomyopathy or myocarditis.
Kuethe F; Lindner J; Matschke K; Wenzel JJ; Norja P; Ploetze K; Schaal S; Kamvissi V; Bornstein SR; Schwanebeck U; Modrow S
Clin Infect Dis; 2009 Dec; 49(11):1660-6. PubMed ID: 19863443
[TBL] [Abstract][Full Text] [Related]
39. Prenatal diagnosis of congenital parvovirus B19 infection: value of serological and PCR techniques in maternal and fetal serum.
Dieck D; Schild RL; Hansmann M; Eis-Hübinger AM
Prenat Diagn; 1999 Dec; 19(12):1119-23. PubMed ID: 10590428
[TBL] [Abstract][Full Text] [Related]
40. Detection of parvovirus B19 infection in first and second trimester fetal loss.
de Krijger RR; van Elsacker-Niele AM; Mulder-Stapel A; Salimans MM; Dreef E; Weiland HT; van Krieken JH; Vermeij-Keers C
Pediatr Pathol Lab Med; 1998; 18(1):23-34. PubMed ID: 9566279
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]